WoundWand
Research type
Research Study
Full title
A Pilot Study of the WoundWand™ Debridement Device on Infection Prevention
IRAS ID
143745
Contact name
Frank Bowling
Contact email
Sponsor organisation
ArthroCare Corporation
Research summary
This is a research study for individuals requiring a surgical procedure for the treatment of an acute wound, a chronic wound, a diabetic foot ulcer, or a venous leg ulcer. This study will evaluate 2 different treatments which are currently used as standard practice: Sharp Debridement [i.e., sharp instruments that remove areas of necrotic (non-living) tissue] and Radiofrequency Debridement (i.e., electrical energy that removes areas of necrotic tissue at relatively low temperatures).
The Radiofrequency Debridement devices being used in this study are Conformité Européenne (CE) marked and currently used on the market in Europe.
The study doctor would normally use either one of the standard practice methods, Sharp Debridement or Radiofrequency Debridement, to treat these wounds, but it is not known if one of these is better than the other. This study is being conducted to count the number of bacteria in treated wounds following Sharp Debridement versus Radiofrequency Debridement.
REC name
North West - Preston Research Ethics Committee
REC reference
13/NW/0801
Date of REC Opinion
28 Nov 2013
REC opinion
Further Information Favourable Opinion